Dai Takehara
Commentary on Protein-Protein and Protein-Peptide Interactions, peptidomimetics and related topics in drug discovery.

Dai Takehara

Dai Takehara joined PRISM in 2011 as CFO and succeeded CEO from a founder in 2016. Before joining PRISM BioLab, he was a management member of healthcare related startup companies, ZIOsoft and Advantage Risk Management. He started his career at Recruit Co., Ltd. He received an MBA from the Kellogg School of Management, and BS from Kyoto University.

Scroll to top